R. Stuart‐Harris

3.6k citations

44 papers · 2.3k indexed · 1 hit paper · h-index 21

Oncology top 2%
- Cancer Treatment and Pharmacology 8
- Lung Cancer Research Studies 5
Cancer Research top 5%
- Breast Cancer Treatment Studies 5
Surgery top 5%
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations 4
- Sarcoma Diagnosis and Treatment 4
Pathology and Forensic Medicine top 5%
Epidemiology
- Neuroendocrine Tumor Research Advances 5
Genetics
- Estrogen and related hormone effects 5
Reproductive Medicine
- Ovarian cancer diagnosis and treatment 4

Co-authors: Derek Raghavan Carlos Caldas Sarah E. Pinder Paul D.P. Pharoah Michael F. Sarosdy Ian F. Tannock Patrick J. Loehrer Lawrence H. Einhorn
Cited by: Oncology Cancer Research Surgery
Partner nations: Australia United Kingdom Belgium

In The Last Decade

R. Stuart‐Harris

44 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

1992 A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

Peers

Countries citing papers authored by R. Stuart‐Harris

Since Specialization

Citations

This map shows the geographic impact of R. Stuart‐Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Stuart‐Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Stuart‐Harris more than expected).

Fields of papers citing papers by R. Stuart‐Harris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Stuart‐Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Stuart‐Harris. The network helps show where R. Stuart‐Harris may publish in the future.

Co-authorship network

The 25 scholars most cited alongside R. Stuart‐Harris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Stuart‐Harris Line = papers co-authored together R. Stuart‐Harris links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours Belinda Thewes,PN Butow,Melanie L. Bell,Jane Beith,R. Stuart‐Harris,Marisa Grossi,Anne Capp,D. Dalley	2012	180
2	Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort Kerri Beckmann,John M. Buckingham,Paul Craft,Jane E. Dahlstrom,Y. Zhang,David Roder,R. Stuart‐Harris	2010	49
3	The prognostic significance of single hormone receptor positive metastatic breast cancer: An analysis of three randomised phase III trials of aromatase inhibitors R. Stuart‐Harris,Bruce Shadbolt,Charlotte Palmqvist,Hilary A. Chaudri Ross	2009	22
4	Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients R. Stuart‐Harris,Carlos Caldas,Sarah E. Pinder,Paul D.P. Pharoah	2008	335
5	Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study Paul R. Harnett,Martin Buck,Philip Beale,Amanda Goldrick,Simon Allan,Bernard M. Fitzharris,Paul de Souza,Matthew Links,Ghulam H. Kalimi,T. Davies,R. Stuart‐Harris	2007	14
6	Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel—ANZGOG 02-01 Anna V. Tinker,Val Gebski,Bernard M. Fitzharris,Martin Buck,R. Stuart‐Harris,Philip Beale,Amanda Goldrick,Danny Rischin	2006	19
7	Continuous infusion of vincristine, ifosfamide and epirubicin over 6 weeks in treatment-resistant advanced breast cancer Howard Gurney,Paul R. Harnett,R. Stuart‐Harris,Richard Kefford	1995	4
8	The Sacred Heart Hospice: an Australian centre for palliative medicine R. Stuart‐Harris	1995	2
9	Hypercalcaemia in small cell lung cancer: Report of a case associated with parathyroid hormone-related protein (PTHrP) R. Stuart‐Harris,Verity Ahern,Janine A. Danks,Howard Gurney,T. John Martin	1993	6
10	The histopathological classification of small cell lung cancer: application of the IASLC classification in 124 cases R. Stuart‐Harris,Michael Boyer,Merle L. Greenberg,S.M.B. Stevens,T. Yung	1992	1
11	A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.breakdown → Patrick J. Loehrer,Lawrence H. Einhorn,Paul Elson,Emily Crawford,Philip Kuebler,Ian F. Tannock,Derek Raghavan,R. Stuart‐Harris,Michael F. Sarosdy,B A Lowe	1992	752
12	Single institutional experience with non‐seminomatous germ cell tumours of the testis: local perspectives on a curable cancer Mark Rosenthal,R. Stuart‐Harris,K. W. Tiver,A.O. Langlands,Richard Kefford	1991	2
13	Identifying priorities of psychosocial need in cancer patients LP Liang,Dunn Sm,Ashleigh Gorman,R. Stuart‐Harris	1990	53
14	CHEMOTHERAPY FOR SMALL CELL LUNG CANCER: INPUCTION AND REINDUCTION WITH VOCA R. Stuart‐Harris,Derek Raghavan,R. H. Fox,Galit Peretz,Catherine Crombie,N. Teriana,Ian Young,P.T. Bye,K. W. Tiver,D. Green	1987	4
15	Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer. J. Bishop,Derek Raghavan,R. Stuart‐Harris,George Morstyn,R. S. Aroney,Richard Kefford,K. Yuen,J Lee,Peter Gianoutsos,Ian Olver	1987	88
16	Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study. E. Eisenhauer,William K. Evans,Derek Raghavan,Marie DesMeules,Nancee Murray,R. Stuart‐Harris,Kaycee Wilson	1986	28
17	Mitoxantrone: An active new agent in the treatment of advanced breast cancer R. Stuart‐Harris,Thomas Bozek,NicholasA. Pavlidis,IanE. Smith	1984	48
18	Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer. Ian E. Smith,Adrian L. Harris,R. Stuart‐Harris,H.T. Ford,J C Gazet,H White,Clive Harmer,Lindsey Carr,J A McKinna,Myfanwy Morgan	1983	11
19	Chlorpromazine, placebo and droperidol in the treatment of nausea and vomiting associated with cisplatin therapy R. Stuart‐Harris,Robert Buckman,I.D. Starke,E. Wiltshaw	1983	11
20	Chemotherapy of Endodermal Sinus Tumour (Yolk Sac Tumour) of the Ovary: Preliminary Communication E. Wiltshaw,R. Stuart‐Harris,G H Barker,N. F. C. Gowing,Sivashanmugam Raju	1982	28

About R. Stuart‐Harris

R. Stuart‐Harris is a scholar working on Oncology, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (5 papers), Estrogen and related hormone effects (5 papers), Breast Cancer Treatment Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (400 citations) and Surgery (857 citations). R. Stuart‐Harris has collaborated with scholars based in Australia, United Kingdom and Belgium. Frequent co-authors include Derek Raghavan, Carlos Caldas, Sarah E. Pinder, Paul D.P. Pharoah, Michael F. Sarosdy, Ian F. Tannock, Patrick J. Loehrer, Lawrence H. Einhorn, Paul Elson and B A Lowe.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact